| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Eli Lilly's commitment to innovation is evident through its advancements in drug development, particularly in obesity and diabetes medications like Mounjaro and Zepbound. The recent FDA approval of Omvoh for ulcerative colitis and the promising results from clinical trials for various conditions further underscore its leadership in the pharmaceutical industry. These initiatives reflect a strong focus on addressing serious medical needs and improving patient outcomes. However, the competitive nature of the pharmaceutical market presents ongoing challenges for sustained growth. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.4 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.2 on 2025-10-28. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3.5) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-28 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | 5.5 | |||||||
| 2025-10-27 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-10-26 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-10-25 | 0%(0%) | 0 | 0% | 0.4 | 3.4 | -1 | |||||||
| 2025-10-24 | 0%(0%) | 0 | 0% | 0.5 | 3.9 | 6 | |||||||
| 2025-10-23 | 0%(0%) | 0 | 0% | 0.3 | 2.8 | -1 | |||||||
| 2025-10-22 | 0%(0%) | 0 | 0% | 0.2 | 2.4 | -1 | |||||||
| 2025-10-21 | 0%(0%) | 0 | 0% | 0.4 | 3.1 | -1 | |||||||
| 2025-10-20 | 0%(0%) | 0 | 0% | 0.4 | 3.2 | -1 | |||||||
| 2025-10-19 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-28 17:50:38 The mention of the Investing Club and market updates suggests a wider trend in financial literacy and timely trading information. |
| 2025-10-28 17:50:38 Nvidia's announcement of new partnerships highlights the company's strategy to expand its influence and collaboration within the tech industry. |
| 2025-10-28 17:50:38 The focus on Eli Lilly's weight loss pill indicates a significant development in healthcare products aimed at addressing obesity. |
| 2025-10-28 17:02:18 Broad expectations regarding the financial outcomes of pharmaceutical companies suggest trends in investor confidence and market dynamics. |
| 2025-10-28 17:02:18 Sentiment in the market regarding pharmaceutical stocks is shaped by recent performance and expectations from earnings reports. |
| 2025-10-28 17:02:18 Investors are considering the rationale behind buying, selling, or holding stocks based on available analyst insights. |
| 2025-10-28 17:02:18 Analyst recommendations play a significant role in influencing investor decisions and stock valuations, highlighting the importance of expert opinions. |
| 2025-10-28 17:02:18 The upcoming third-quarter earnings reports from major pharmaceutical companies are closely monitored for performance insights and stock market impact. |
| 2025-10-28 09:35:47 The article references anticipation for a potential launch next year, implying the influence of regulatory approval processes on market availability. |
| 2025-10-28 09:35:47 The production of billions of doses reflects a strong expectation of high demand in the weight-loss market, showcasing a significant industry trend. |
| 2025-10-28 09:35:47 Eli Lilly is advancing the development of new weight-loss medication, indicating a strong focus on health-related pharmaceutical breakthroughs. |